Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZR101 vs Insulin Degludec/Insulin Aspart in Type 2 Diabetes
NCT06199505Phase 2Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Nov 2023
- Primary completion
- Jun 2024
- Modality
- Insulin and Analogs
- Countries
- 1
01
Overview
A Phase 2 trial of GZR101 in type 2 diabetes mellitus (T2DM), sponsored by Gan & Lee Pharmaceuticals. Started Nov 2023; status: completed.
02
Drugs
GZR101
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06199505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06199505.